InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Lang James Paul, Director. Insider active across 3 companies, notably OptimizeRx Corp. In total, 11 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €2.3m. Activity tracked since 30 June 2021. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lang James Paul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
889 shares0Restricted Stock UnitsSEC:0001159036-26-000007:0
9,868 shares0Common StockSEC:0001628280-25-031022:0
321,408 shares@ US$7.603395.8% of flowCommon StockSEC:0001628280-25-013918:0
Canonical exit: 12 Jun 2025 (T+90)
10,061 shares0Common StockSEC:0001628280-24-027709:0
4,637 shares0Common StockSEC:0001628280-23-029928:0
657 shares0Common StockSEC:0001628280-23-010323:0
43,578 shares0COMMON STOCKSEC:0001520138-23-000059:0
409 shares0Common StockSEC:0001628280-23-000210:0
334 shares0Common StockSEC:0001628280-22-025811:0
6,000 shares@ US$16.45394.2% of flowCommon StockSEC:0001213900-22-050556:0
Canonical exit: 17 Nov 2022 (T+90)
407 shares0Common StockSEC:0001213900-21-035078:0
11 of 11 declarations
About Lang James Paul
Lang James Paul is Administrateur at OptimizeRx Corp, Halozyme Therapeutics, INC. and BIOVIE INC. He has 11 filings in total, and across the 11 sampled filings between 2021-06-30 and 2026-01-06, the transactions are buys for EUR 2348988 and no sells, with Levée d'options as the most frequent transaction nature.
